CARLA R FAZIO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MIAMI, FL NPI 1013348085
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$3,062.65
- Category: General Payments
- Program years: PY2021–2024
- Record count: 134
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $982.80 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $982.80 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $129.43 | 5 |
| Daiichi Sankyo Inc. | $103.46 | 5 |
| Celgene Corporation | $77.93 | 4 |
| GlaxoSmithKline, LLC. | $68.46 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.59 | 2 |
| Janssen Biotech, Inc. | $47.36 | 2 |
| Acerta Pharma LLC | $43.90 | 2 |
| Ipsen Biopharmaceuticals, Inc | $43.73 | 2 |
| Lilly USA, LLC | $39.79 | 2 |
| GENZYME CORPORATION | $38.71 | 2 |
| Astellas Pharma US Inc | $35.69 | 2 |
| TerSera Therapeutics LLC | $33.29 | 1 |
| PFIZER INC. | $32.54 | 2 |
| ABBVIE INC. | $32.13 | 2 |
| AVEO Pharmaceuticals, Inc. | $30.06 | 1 |
| Incyte Corporation | $27.91 | 1 |
| Genmab U.S., Inc. | $25.54 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.31 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.24 | 1 |
| Adaptive Biotechnologies Corporation | $20.45 | 1 |
| ARRAY BIOPHARMA INC | $19.44 | 1 |
| EMD Serono, Inc. | $15.69 | 1 |
| Gilead Sciences, Inc. | $15.15 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.